Oncomatryx Biopharma S.L.
Oncomatryx Biopharma S.L.
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma | Pancreatic Adenocarcinoma Metastatic | Recruiting | Phase 1 | 2026-01-29 | NCT07377045 | |
| Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors. | Advanced Solid Tumor | Recruiting | Phase 1 | 2025-11-25 | NCT05547321 |